No detectable untoward results on nonneoplastic cells, in vitro. Although it blocks competitively the binding of dihydrotestosterone (DHT) to its protein receptor, it's no significant results on possibly estrogen or progesterone receptors. A stable-period process with the synthesis of tentoxin has been produced and should be relevant to the technology https://gregoryiaskb.snack-blog.com/26629133/detailed-notes-on-enrasentan